3649 results for «446»
3649 results
Why mechanical thrombectomy should be considered in the management of acute pulmonary embolism
16 May 2024 – From EuroPCR 2024
In this EuroPCR 2024 session, study the case of a patient with high-risk pulmonary embolism and another with intermediate to high-risk pulmonary embolism, delve into discussions on clinical evidence for mechanical thrombectomy in pulmonary embolism, acquire skills to evaluate eligibility for mechanical thrombectomy, and learn how to...
Ultra-low contrast techniques to improve the safety and quality of PCI in complex and high-risk patients
14 May 2024 – From EuroPCR 2024
Tune in to this session to discover how reducing reliance on contrast opacification enhances procedural safety and enables more thorough revascularization in complex PCI scenarios. Learn that ultra-low contrast (ULC) PCI encompasses various interventional skills and specialized tools, many already familiar to interventional cardiologists. Embrace a...
Revisiting thrombus aspiration in STEMI with continuous power aspiration system
15 May 2024 – From EuroPCR 2024
Tune into this 2024 session for insights into the latest ESC guidelines, strategies to prevent and treat no reflow, and an examination of trials like TASTE, TAPAS, and TOTAL on coronary thrombus management. Explore also the outcomes of the CHEETAH study, pondering a potential paradigm shift,...
Solving challenging PCI with laser atherectomy: the forgotten Swiss knife?
15 May 2024 – From EuroPCR 2024
Watch this session to enhance your understanding of laser atherectomy fundamentals, recognize its role in addressing complex lesions like in-stent restenosis and uncrossable lesions, and acquire tips and techniques for ensuring procedural efficiency and safety.
Elevating quality of heart valve treatment through innovation: SAPIEN 3 Ultra RESILIA and EVOQUE valve systems
14 May 2024 – From EuroPCR 2024
Watch this session to explore how the SAPIEN 3 Ultra RESILIA valve can enhance lifetime management for patients, to find out more about the new treatment options available with the EVOQUE valve, identifying the patient populations that stand to benefit the most, and, additionally, to get...
PASCAL Precision system simulation showcase: grasp the difference!
16 May 2024 – From EuroPCR 2024
In this EuroPCR 2024 session, explore a transcatheter edge-to-edge mitral valve repair case, delve into discussions backed by simulation, evidence, and real-world cases to understand atraumatic clasp and closure techniques and predictable implant release. Additionally, gain insights into real-world evidence for tricuspid TEER from the EuroTR trial...
Restoring vessel physiology drives outcomes - The Bioadaptor experience
16 May 2024 – From EuroPCR 2024
Join this session to delve into the unmet needs concerning drug-eluting stents (DES), including poor long-term clinical outcomes, with up to a 50% MACE rate at 10 years, and a non-plateauing 2-3% annual event rate. Explore how DynamX Bioadaptor technology addresses these challenges by maintaining the...
Multivessel disease PCI guided by physiology and IVUS - LIVE case
16 May 2024 – From EuroPCR 2024
A 78-year-old woman with hypertension, dyslipidemia, and obesity, presented with angina CCS2 and preserved LV function. The coronary angiogram showed stenosis in the RCA (proximal and mid), CX, and calcified proximal and mid LAD involving D1 and D2.
The operators performed PCI on the RCA (1 stent)...
ANOCA/INOCA: when angiography is not enough to reach a diagnosis
16 May 2024 – From EuroPCR 2024
This session provides practical knowledge on the diagnosis and management of patients with ANOCA/INOCA (Angina with Non-Obstructive Coronary Arteries/Ischemia with Non-Obstructive Coronary Arteries). It covers the evaluation of microvascular and vasomotor disorders in patients with non-obstructive coronary arteries, and the causes and management of patients with...
TAVI updates: expanding indications
14 May 2024 – From EuroPCR 2024
This session presents the latest updates and evidence on the expanding indications for transcatheter aortic valve implantation (TAVI). It covers topics such as the impact of unfavorable aortic valve anatomy on TAVI outcomes, sex-specific differences in cardiac damage in aortic stenosis patients undergoing TAVI, the use...
PCI complications: mistakes in stent placement, stent elongation during implantation & more
16 May 2024 – From EuroPCR 2024
This session comprises selected EuroPCR 2024 Clinical Case submissions focusing on various PCI complications, including mistakes in stent placement, stent elongation during implantation, and unexpected stent behavior after post-dilatation. The cases are presented with interactive discussions to enhance understanding of these complex scenarios and their management.
Thrombectomy for pulmonary embolism
16 May 2024 – From EuroPCR 2024
This session, comprising selected EuroPCR 2024 Abstract submissions, focuses on catheter-directed therapy for pulmonary embolism. It includes presentations and discussions on an intelligent CT vacuum aspiration thrombectomy system, outcomes of catheter-directed therapy in intermediate-high and high-risk pulmonary embolism, and functional and quality of life outcomes in...
"Rock" around the clock: differential use of the dedicated tools to deal with coronary calcific lesions
16 May 2024 – From EuroPCR 2024
This session, with the collaboration of the Argentinian College of Interventional Cardioangiologists (CACI), Italian Society of Interventional Cardiology (SICI-GISE) and Interventional Department of the Chilean Society of Cardiology, provides insights on modern treatment algorithms for calcific coronary lesions. It covers best practices for different devices to...
CTO PCI: from planning to execution
16 May 2024 – From EuroPCR 2024
This session, with the collaboration of the Cyprus Society of Cardiology / Cyprus Interventional Cardiology Working Group, Tunisian Group for Interventional Cardiology and Bulgarian Society of Interventional Cardiology, covers planning and execution of CTO PCI procedures. It includes case discussions on treatment dilemmas, overcoming frequently encountered...
Comparative insights into QFR, FFR, and angiography
16 May 2024 – From EuroPCR 2024
This session, comprising selected EuroPCR 2024 Abstract submissions, focuses on various aspects of assessing and managing multivessel coronary artery disease. It includes presentations and discussions on the use of quantitative flow ratio (QFR) for assessing non-culprit lesions in acute myocardial infarction, functional assessment of surgical revascularization,...
PCR's Got Talent - Round 2 - Session 1
15 May 2024 – From EuroPCR 2024
Randomised trials: substudies and extended follow-up - A quick update
15 May 2024 – From EuroPCR 2024
This session provides a quick update on various randomised trials, including substudies and extended follow-up data. It covers insights on bifurcation stenting, the symptom-stratified analysis of ORBITA-2, the impact of completeness of revascularisation on clinical outcomes from REVIVED-BCIS2, cost-effectiveness of CABG vs. PCI from FAME 3,...
TEER for primary mitral regurgitation - LIVE case
15 May 2024 – From EuroPCR 2024
A 76-year-old male, with previous CABG in 2015, hypertension, diabetes, and pulmonary hypertension (WHO2), presented with severe symptomatic primary MR (P3 flail).
The operators implanted 1 MitraClip (XTW) step-by-step, from the transseptal puncture to the closure, guided by TEE echo and under general anaesthesia, via the venous...
Upgrade to retrograde: when and how?
16 May 2024 – From EuroPCR 2024
This session delves into the decision-making for transitioning to a retrograde approach in CTO PCI, covering effective techniques and safety considerations for successful outcomes, through cases involving antegradely induced hematomas and ambiguous CTO caps, alongside severe distal atherosclerosis.
Edge-to-edge repair for primary mitral regurgitation: the good, the bad and the ugly
16 May 2024 – From EuroPCR 2024
Discover how to select suitable patients for TEER of primary mitral regurgitation, tackle anatomical challenges, understand the technique's limits, and gain insights into managing complexities and identifying cases where TEER may not be ideal.
